Svenska Dokumentmallar
Medical Devices – interruption of supply under MDR/IVDR Article 10a | Word/PDF/Excel
Medical Devices – interruption of supply under MDR/IVDR Article 10a | Word/PDF/Excel
- File format
- DOCX, PDF, XLSX
- Document language
- Five Swedish workbooks one Swedish guide one English User Guide; Excel in Swedish; no English master workbooks
- Number of files
- 7
Digital download. No physical product is shipped.
Couldn't load pickup availability
About this template
Do you need to manage a planned supply disruption or the discontinuation of a medical device or IVD product? This document package helps Swedish manufacturers, importers, and distributors collect risk assessment data, decide whether to notify, forward the manufacturer's information, and retain records. Important: Article 10a is not triggered by every supply delay. Assess whether the disruption could lead to serious harm or the risk of serious harm to patients or public health. The package does not replace the authority's official forms or medical/regulatory expertise.
Quick facts and who the template is for
Document type: operational compliance and evidence package. Legal: MDR/IVDR Article 10a (EU), Swedish authority process where the competent authority is the Swedish Medical Products Agency. Files: 7 editable Word (.docx), 7 searchable printable PDFs, and 1 Excel (.xlsx) with nine tabs – 15 files in total. Language: five Swedish working templates, Swedish guide, and English User Guide; the Excel file is in Swedish. The English guide does not translate the working templates. PDF: not interactive fillable forms. Delivery: digital ZIP after future manual activation; this product is not yet published or linked to Digital Products.
01 – Package contents
Five Swedish working documents (risk assessment, notification decision, manufacturer data, forwarding, and recipient log), Swedish user guide, and separate English user guide. All seven are available as both DOCX and searchable PDF. In addition, a Swedish Excel register. Seven independent documents, 15 customer files.
02 – What the files contain
Role and product delimitation, medical risk questionnaire, reasoned notification decision, checklist for official authority notification, faithful transmission to downstream recipients, transmission and receipt evidence, and action log. Excel compiles administrative cases and open actions without automatically determining legal compliance.
Who should choose the package – and when is it not suitable?
Situation 1: A manufacturer anticipates that the availability of an affected product will cease and needs to document patient risk, affected Member States, and recipients before notifying the authority. Situation 2: An importer/distributor has received the manufacturer's Article 10a notification and needs to forward the original information without unnecessary delay, as well as save transmission evidence.
Choose other documentation for ordinary supply planning only without relevant serious risk, for clinical assessment of a replacement product, or for MDR/IVDR registration in EUDAMED. Specially adapted products are not covered by Article 10a under the specified EU regulation; the classification must be checked. Old so-called legacy products may be covered.
Exact file list
| Document | Use | Language | Format |
|---|---|---|---|
| 01 Applicability and risk assessment | Identify product/actor, assess relevant serious patient/public health risk, and document uncertainty | SV | DOCX + PDF |
| 02 Action and notification decision | Justify decision, recipients, planned actions, and actual date | SV | DOCX + PDF |
| 03 Manufacturer's notification data | Prepare facts for official MDCG form and authority process | SV | DOCX + PDF |
| 04 Faithful transmission | Cover letter, unaltered manufacturer original, and distribution tracking | SV | DOCX + PDF |
| 05 Recipient and action log | Transmission evidence, receipts, follow-up, and closure check | SV | DOCX + PDF |
| 06 User guide | Preparations, workflow, exceptions, and checklist | SV | DOCX + PDF |
| 07 English User Guide | English instructions for using the Swedish working documents | EN | DOCX + PDF |
| 08 Evidence register | Cases, risk assessments, products, recipients, notifications, forwarding, and actions | SV | XLSX |
The Word files are editable; the PDF files can be read, searched, and printed but lack interactive form fields. Excel requires spreadsheet software that supports XLSX formulas and data validation, preferably Microsoft Excel. No macros are included.
The Excel tool in practice
The workbook has nine tabs: Start, Cases, Risk assessment, Products, Recipients, Notifications, Forwarding, Actions, Read me, and Sources. The start page uses controlled COUNTA/COUNTIF formulas for the number of registered/ongoing cases, unassessed risks, sent notifications, unacknowledged recipients, and open actions. Example: if a recipient has the status “Unacknowledged,” it is displayed in the summary, but this does not mean that the message was actually missed or that a legal requirement is automatically met.
Workflow from forecast to evidence
- Identify product, manufacturer, MDR/IVDR status, and projected disruption.
- Let the relevant medical/regulatory function assess the threshold for serious harm or risk.
- Document justification, recipient group, date, any exceptions, and realistic actions.
- For manufacturer obligation: check the current official MDCG 2024-16 Manufacturer Information Form and the correct competent authority; do not send only this Word template.
- As importer/distributor: forward the manufacturer's original unaltered without unnecessary delay to relevant direct customers.
- Document actual transmission evidence/receipts and follow up on consequences and changes.
Legal requirements
Regulation (EU) 2024/1860 introduced Article 10a in both MDR and IVDR. The requirement has been applied since January 10, 2025. When the manufacturer's planned disruption or discontinuation can reasonably be expected to lead to serious harm or the risk of serious harm, the manufacturer must normally inform the competent authority and specified direct recipients at least six months in advance, except in exceptional circumstances. Article 10a.3 further applies to forwarding downstream without unnecessary delay. The correct recipient authority depends on the manufacturer's or authorized representative's country of establishment; the Swedish Medical Products Agency is not always competent.
See the Swedish Medical Products Agency's instructions and the European Commission's MDCG guidance and forms. An authority form must be checked separately; it is not included as a replacement in the package. Individual clinical assessment and any other product liability/recall actions require separate expertise.
Compare with related documents
EUDAMED – registration and UDI helps with other regulatory administration. A general supplier or risk management agreement does not replace a role-specific Article 10a notification. The product's Excel register is not an inventory planning system or clinical decision support.
Frequently asked questions
Must all supply delays be reported?
No. Article 10a presupposes the described risk of serious harm or the risk of serious harm; assess and document the circumstances.
Do the same obligation apply to manufacturers and distributors?
No. The manufacturer primarily assesses reporting and information under Article 10a.1. Downstream economic operators forward the received manufacturer information under Article 10a.3.
Is it enough to send the Word template to the Swedish Medical Products Agency?
No. The manufacturer's Word template is an internal preparation document. Check and use the current official form and relevant submission instructions.
Can Excel determine if the six-month deadline has been met?
No. Excel reports actual registrations and status, not a legal deadline assessment or authority confirmation.
Are the PDF files fillable or the templates in English?
The PDF files are searchable and printable, but not interactively fillable. The main templates are in Swedish; only the user guide is available separately in English.
Version, sources, and transparency
Edition 1.0, November 14, 2026. AI-assisted legal source review and internal file check have been performed as of this date; no independent lawyer, legal, medical expert, or authority review is claimed. Forms, authority instructions, affected products, and risk assessment must be checked at actual use. Trademark: Mallbutiken.se; supplier: Svenska Dokumentmallar.
